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Abstract: The purpose of this study was to determine the characteristics of primary diffuse 
large B-cell lymphoma (DLBCL) of the lacrimal sac. A 77-year-old man had epiphora of 
the right eye for three years. After visiting five clinics and hospitals, he was referred to our 
  hospital, and the preoperative magnetic resonance imaging findings suggested a lacrimal 
sac mass. Dacryocysteography showed an obstruction of the right nasolacrimal duct, so we 
  performed dacryocystectomy. After a histopathologic examination of the specimen, the patient 
was diagnosed with a DLBCL. Positron emission tomography scanning excluded metastases, 
and the final diagnosis was made of a primary DLBCL of the right lacrimal sac. He underwent 
radiotherapy with 30.6 Gray in total to the right lacrimal sac. After radiotherapy, no recurrence 
has been observed anywhere in his body for one year. Although a malignant lymphoma of the 
lacrimal sac is rare, clinicians should consider a primary malignant lymphoma in the differential 
diagnosis in patients with chronic dacryocystitis.
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Introduction
Primary malignant lymphoma of the lacrimal sac is rare but potentially life-threatening. 
In Europe, extranodal marginal zone B-cell lymphomas of the mucosa-associated 
lymphoid tissue (MALT lymphoma) and diffuse large B-cell lymphoma (DLBCL) 
are major malignant lymphomas of the lacrimal sac.1 However, it is not clear what 
the characteristics of a major malignant lymphoma of the lacrimal sac are in Japan 
because there are only a small number of cases reported.2–8
We have examined a patient with primary DLBCL of the lacrimal sac and reviewed 
Japanese patients with primary malignant lymphoma of the lacrimal sac to compare 
the characteristics of Japanese patients with those of Caucasian patients.
Case report
A 77-year-old man had epiphora of the right eye of three years’ duration and had 
visited three private clinics. His symptoms did not improve with the prescribed 
medical treatments, and he had noted a painless stiffness in the right lacrimal area 
six months earlier. After a visit to a fourth private clinic, he was referred to the San-
noh Medical Center for a magnetic resonance imaging (MRI) examination. The MRI 
findings (Figure 1A–C) suggested a lacrimal sac mass, and he was referred to Chiba 
University Hospital.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Figure 1 Preoperative MRI and dacryocysteographic findings in a 77-year-old patient. Both magnetic resonance imaging examinations of T1 images (A, B) and T2 image (C) 
show a low or isointensity mass in the right lacrimal sac without invasion of surrounding tissues, which is consistent with histopathologic examination; the adjacent epithelium 
was not invaded by lymphoma cells. Dacryocysteography shows an obstruction of the right nasolacrimal duct (D, E).
At the first examination, his visual acuities were 0.9 
OD and 1.0 OS. The intraocular pressures were within the 
normal range, and the fundi of both eyes were normal. The 
right lacrimal duct was blocked. The painless stiffness in the 
right lacrimal sac area was palpable, but the stiffness had not 
increased for six months. We performed dacryocysteogra-
phy, and an obstruction of the right nasolacrimal duct was 
confirmed (Figure 1D–E).
We planned to perform dacryocystorhinostomy with a 
rapid pathologic examination during the operation. This 
examination showed evidence of a malignant lymphoma 
(Figure 2A). Thus, we changed the surgical method from 
dacryocystorhinostomy to dacryocystectomy. Hisopatho-
logic examination of the resected specimen revealed dif-
fuse proliferation of atypical lymphocytes with prominent 
nucleoli. There was no lymphoepithelial lesion. Immuno-
histochemically, the atypical lymphocytes were positive 
for CD20 (L26), CD79a, and CD10, and negative for CD3, 
CD45RO (UCHL-1), CD5, and cyclin D1 (Figure 2B–F). 
A final diagnosis of DLBCL was made from these find-
ings. Postoperative positron emission tomography scanning 
excluded metastases throughout the body. Thus, the final 
diagnosis of his mass was a primary DLBCL of the right 
lacrimal sac.
He underwent radiotherapy with 30.6 Gray in total to the 
right lacrimal sac. After the radiotherapy, no recurrence has 
been observed anywhere in his body for one year.
Discussion
The first report of a primary malignant lymphoma of the 
lacrimal sac in Japan was a case of non-Hodgkin’s B-cell 
lymphoma in 1997.2 The patient had had epiphora for one 
year followed by a painless swelling of the lacrimal area 
for three months. Although a precise classification was 
not reported, it may have been a DLBCL.2 In the second 
case of B-cell lymphoma, the patient had epiphora and 
discharge, and was treated for chronic dacryocystitis 
for 9–10 months.6 The correct diagnosis may have also 
been DLBCL.6 Our case is the third documented case 
of primary DLBCL of the lacrimal sac in Japan, and our 
patient had also been treated as chronic dacryocystitis for 
three years.
Merkonidis et al reported that of 1294 biopsies of the 
lacrimal sac walls obtained during dacryocystorhinostomy 
in seven studies, only one (0.08%) specimen was found to 
be a malignant lymphoma.9 Earlier studies reported that of 
15 primary lacrimal sac lymphomas, 33% were DLBCL and 
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  lymphomas.1 Therefore, MALT lymphoma was to be 
considered in the   differential diagnosis of the mass in our 
patient. We ruled out MALT lymphoma by the histologic 
features and immunohistologic results, including absence of 
lymphoepithelial lesion that is common in MALT   lymphoma 
and weak expression of CD10 that is incompatible with 
MALT lymphoma.
Clinical data for Japanese patients with primary lac-
rimal sac lymphoma are presented in Tables 1 and 2. It is 
not clear what the pathognomic signs of major malignant 
lymphoma of the lacrimal sac in Japan are because there 
are only seven reported cases. A recent study reported five 
(5.2%)   malignant lymphomas of the lacrimal sac of all 
primary lacrimal sac tumors in Chinese patients.10 All of 
the   malignant lymphomas of the lacrimal sac in the Chinese 
patients were diagnosed as MALT lymphoma.10 In addi-
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Figure 2 Representative histopathologic findings of frozen section (A) and histopathologic findings in the surgical specimen of the right lacrimal sac tumor (B–F). Diffuse 
proliferation of atypical lymphoid cells can be seen. Atypical nuclei with prominent nuclei are present, which suggest a malignant tumor including malignant lymphoma A. 
Hematoxylin and eosin staining showed large lymphoid cells with high-density nuclei (B). Immunostaining with L26 C and CD79a (D) are strongly positive, and CD10 (E) is 
weakly positive on the membrane of lymphoid cells. The adjacent epithelium was not invaded by lymphoma cells (cytokeratin, CAM5.2, (F)).
Table  1  Characteristics  of  Japanese  patients  with  malignant 
lymphoma of the lacrimal sac. There are a small numbers of cases 
reported  in  Japan.  We  identified  seven  patients  with  primary 
lacrimal sac lymphoma, of which two cases were DLBCL,2,6 two 
were diffuse medium cell type lymphoma with B-cell markers,3,5 one 
was a MALT lymphoma,7 and one was a primary T-cell malignant 
lymphoma.8 The first case of a natural killer cell lymphoma of the 
lacrimal sac was reported by Mori et al.4 Compared with Caucasian 
patients, primary malignant lymphomas of the lacrimal sac are rare 
and MALT lymphomas are infrequent in Japanese patients
Japanese Caucasians
DLBCL 2 DLBCL 33%
MALT 1 MALT 33%
Peripheral T-cell lymphoma 1 Transitional MALT lymphoma 13.3%
NK lymphoma 1
Medium cell type lymphoma  
with B-cell markers 2
Abbreviations: DLBCL, diffuse large B-cell lymphoma; MALT, mucosa-associated 
lymphoid tissue; NK, natural killer.Clinical Ophthalmology
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Table 2 Clinical data for Japanese patients with primary lacrimal sac lymphoma
Case Age Gender Symptoms Histology T/B Stage Treatment/dose Follow-up/duration Authors
1 70 F epiphora; swelling DLBCL B Ie rT/50Gy CHOP/1 cycle Cr/26 m Nakamura et al2
2 40 F epiphora; discharge DLBCL B Ie NA NA Akizawa et al6
4  55 M swelling DM B Ie rT/40Gy CHOP/NA Cr/21 m Hino et al3
5 78 M epiphora DM T Ie rT/40Gy CHOP/NA Cr/36 m Morimoto et al5
6 55 F NA MALT B NA NA Cr/98 m Takada et al7
7 55 F swelling NA NK IIe CHOP/6 cycles rT/40Gy DOD/9 m Mori et al4
8 77 M epiphora; discharge; swelling DLBCL B Ie rT/30.6Gy Cr/12 m Current report
Abbreviations: CHOP, cyclophosphamide, doxorubicin, vincristine, and prednisone; Cr, complete remission; DLBCL, diffuse large B-cell lymphoma; DM, diffuse medium; DOD, 
dead of disease; F, female; Gy, Gray; m, months; M, male; MALT, mucosa-associated lymphoid tissue; NA, not available; NK, natural killer; T/B, T-cell/B-cell; rT, radiotherapy.
tion, only one case of malignant lymphoma of the lacrimal 
sac has been reported in Malaysia.11 The final diagnosis of 
malignant lymphoma in Malaysia was a small non-cleaved 
B-cell nonHodgkin’s lymphoma.11 Thus, the incidence of 
malignant lymphoma of the lacrimal sac appears to be lower 
in the Asian population than in Caucasians. Although MALT 
lymphomas have lower malignancy rates than any other 
types of malignant lymphoma, MALT lymphomas are rare 
in Japanese patients compared with Caucasian patients or 
Chinese patients.1–10
Although our case had a chronic course, the prognosis 
appeared to be good. One reason for this may be that, during 
the chronic course, MALT lymphomas may be transformed 
to DLBCL, because some DLBCL in the ocular adnexa may 
arise from MALT lymphomas.1,7 In general, MALT lympho-
mas tend to remain in the primary tissue.
In summary, we report a case of primary DLBCL of the 
lacrimal sac. MALT lymphomas are rare in Japanese patients 
compared with Caucasian patients or Chinese patients. Clini-
cians should consider primary malignant lymphoma in the dif-
ferential diagnosis of patients with chronic dacryocystitis.
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